Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Infectious
Harvard team develops compound to combat drug-resistant bacteria
By
Matt Limb
Harvard University researchers say they have created an antibiotic that can overcome many drug-resistant infections.
March 13, 2024
New class of broad-spectrum antivirals could be first line of pandemic defense: Study
By
Nick Paul Taylor
Targeting a cellular pathway has inhibited SARS-CoV-2 and other RNA viruses in preclinical tests, pointing to a potential new class of first-line antivirals with broad effectiveness against emerging pathogens.
March 5, 2024
BioMérieux, FDA to collaborate on combating food-borne pathogens
By
LabPulse.com staff writers
BioMérieux has entered into a strategic research collaboration with the U.S. Food and Drug Administration (FDA) to develop technologies to improve the detection and characterization of food-borne pathogens.
March 1, 2024
Global research network launches to fight strep A infections
By
Matt Limb
Scientists have launched a global research network to combat deadly strep A infections that can trigger sepsis and heart damage in children.
February 27, 2024
Bavarian Nordic ends cancer vaccine program
By
LabPulse.com staff writers
Biotech firm Bavarian Nordic is ceasing all work on its cancer vaccine program, instead prioritizing its infectious disease projects.
February 22, 2024
CRISPR and nanopore technology enable sensitive and specific mpox detection
By
Nick Paul Taylor
A test that combines CRISPR gene editing and nanopore sensing technology could accelerate the detection of mpox and other pathogens, according to a paper published in
Biosensors and Bioelectronics
.
February 16, 2024
T2 Biosystems gets FDA nod to expand bacteria panel
By
LabPulse.com staff writers
T2 Biosystems announced it received 510(k) clearance to add A. baumannii to its T2Bacteria Panel.
February 12, 2024
CARB-X awards funding to Visby Medical for gonorrhea, antibiotic susceptibility test
By
LabPulse.com staff writers
CARB-X will award up to $1.8 million to biotech firm Visby Medical to develop a portable rapid polymerase chain reaction test to detect
Neisseria gonorrhoeae
, the pathogen that causes gonorrhea, including its susceptibility to ciprofloxacin.
February 8, 2024
Cytokine improves outcomes in mice with sepsis, predicts survival in humans
By
Nick Paul Taylor
Administering a protein that correlates to survival in sepsis has improved survival in mice in a study, pointing to a potential new way to treat the life-threatening reaction to infection.
February 6, 2024
U.K. Health Security Agency unveils five-year pathogen genomics strategy
By
Matt Limb
The U.K. Health Security Agency (UKHSA) has unveiled a five-year plan to make pathogen genomics central to protecting public health and combating infectious disease threats.
February 1, 2024
Program to fight sepsis in LMICs launched at SCCM Congress, test data presented
By
Matt Limb
Intensive care professionals have unveiled a program to cut deaths from sepsis in low- and middle-income countries (LMICs) with ambitions to improve access to diagnostic tools, laboratories, and medicines.
January 26, 2024
Concentric by Ginkgo, Illumina to collaborate on biosurveillance technology
By
Matt Limb
Illumina and biosecurity firm Concentric by Ginkgo have pledged to expand biosecurity capabilities to help countries “modernize defenses" against emerging biological threats.
January 24, 2024
Page 1 of 150
Next Page